SPM-0606

N/A

Report date: 2024/12/06 14:39:39
NME

Base Information

Drug NameSPM-0606
Drug Alias NameSPM-0606
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA antagonistsGlutamate receptor ionotropic kainate antagonists
TargetsGlutamate receptor ionotropic AMPAGlutamate receptor ionotropic kainate
Therapy Area/IndicationsAmyotrophic Lateral SclerosisEpilepsyTinnitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSea Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesSea Pharmaceuticals LLCInotiv Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisEpilepsyTinnitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A